pharmaceutical-investing Pfizer Announces Overall Survival Results from Phase 3 PALOMA-3 Trial of IBRANCE in HR+, HER2- Metastatic Breast Cancer
pharmaceutical-investing MacroGenics Provides Update on Corporate Progress and 2017 Financial Results
Merus Announces First Patient Dosed in a Phase 2 Clinical Trial of MCLA-128 in Two Metastatic Breast Cancer Patient Populations
pharmaceutical-investing Cascadian Therapeutics Gets Pediatric Investigation Plan Waiver for Lead Candidate
Eagle Energy Metals Corp. and Spring Valley Acquisition Corp. II Announce Effectiveness of Registration Statement and Record and Meeting Dates for Extraordinary General Meeting of Shareholders to Approve Proposed Business Combination
